Arcutis Announces Positive Topline Data from Phase 2b Study of ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Scalp and Body Psoriasis

Press/Media

Period23 Nov 2020

Media coverage

1

Media coverage

  • TitleArcutis Announces Positive Topline Data from Phase 2b Study of ARQ-154 (Topical Roflumilast Foam) as a Potential Treatment for Scalp and Body Psoriasis
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date23/11/20
    PersonsLeon Kircik
View all 1
View less